Purchase this article with an account.
Michael C Stiles; Trabectome outcomes by single surgeon. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3177.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the efficacy and safety of Trabectome procedure by single surgeon.
A total of 270 cases were included in the study. Patients without pre-operative IOP were excluded. All surgeries were performed by a single surgeon (MCS). Outcome measures include IOP, number of medications and secondary glaucoma surgery, if any. Success was defined as IOP ≤ 21mmHg, IOP reduced by 20% or more from baseline on any two consecutive visits after 3 months. Kaplan-Meier was used for survival analysis.
The mean age of the study group was 71 years old. Majority were Caucasians (82%) diagnosed with primary open angle glaucoma (68%). Average baseline IOP was 23.2±7.1 mmHg with 2.4±1.2 glaucoma medications. At 6 months, the IOP was reduced to 16.9±4.0mmHg (p<0.01) and number of medications was 1.8±1.2 (p<0.01). At 12 months, the average IOP was 15.3±3.5 mmHg (p<0.01) and average number of medications was 1.5±1.2 (p<0.01). Survival at 12 months was 87%. 9 cases (3%) required additional glaucoma surgery. One case of hypotony was noted on day one, but it was quickly resolved.
Trabectome appears to be safe and effective for glaucoma patients.
This PDF is available to Subscribers Only